Romiplate



Indications and Reactions:

Role Indications Reactions
Primary
Idiopathic Thrombocytopenic Purpura 35.7%
Small Intestine Carcinoma 10.0%
Hypertension 9.0%
Constipation 6.2%
Immune Thrombocytopenic Purpura 6.2%
Postoperative Care 4.3%
Prophylaxis 3.8%
Product Used For Unknown Indication 3.3%
Haematochezia 2.9%
Diabetes Mellitus 2.4%
Gastritis 2.4%
Insomnia 1.9%
Osteoporosis 1.9%
Angina Pectoris 1.4%
Diarrhoea 1.4%
Gastric Ulcer 1.4%
Gastrooesophageal Reflux Disease 1.4%
Hyperlipidaemia 1.4%
Hyperuricaemia 1.4%
Mitral Valve Replacement 1.4%
Platelet Count Decreased 9.1%
Therapeutic Response Decreased 9.1%
Cerebral Haemorrhage 7.3%
Death 7.3%
Antibody Test 5.5%
Arteriosclerosis Obliterans 5.5%
Asthma 5.5%
Cerebral Infarction 5.5%
Thrombosis 5.5%
Anaemia Haemolytic Autoimmune 3.6%
Azotaemia 3.6%
Hepatic Function Abnormal 3.6%
Influenza Like Illness 3.6%
Myelofibrosis 3.6%
Myocardial Infarction 3.6%
Petechiae 3.6%
Pneumocystis Jiroveci Pneumonia 3.6%
Pneumonia 3.6%
Respiratory Failure 3.6%
Soft Tissue Infection 3.6%
Secondary
Idiopathic Thrombocytopenic Purpura 47.1%
Epilepsy 7.4%
Gastritis 7.4%
Osteoporosis 7.4%
Diabetes Mellitus 5.9%
Diarrhoea 4.4%
Prophylaxis 4.4%
Hypertension 2.9%
Immune Thrombocytopenic Purpura 2.2%
Angina Pectoris 1.5%
Benign Prostatic Hyperplasia 1.5%
Orthostatic Hypotension 1.5%
Spinal Osteoarthritis 1.5%
Atrial Fibrillation 0.7%
Cardiac Failure 0.7%
Constipation 0.7%
Gastric Ulcer 0.7%
Neuropathy Peripheral 0.7%
Peripheral Arterial Occlusive Disease 0.7%
Thrombosis 0.7%
Liver Disorder 23.3%
Antibody Test 10.5%
Haemorrhage Intracranial 10.5%
Thrombosis 10.5%
Renal Impairment 7.0%
Anaemia Haemolytic Autoimmune 5.8%
Myelofibrosis 5.8%
Hypotension 4.7%
Therapeutic Response Decreased 4.7%
White Blood Cell Count Increased 4.7%
Petechiae 3.5%
Azotaemia 2.3%
Disseminated Intravascular Coagulation 2.3%
Hepatic Function Abnormal 2.3%
Pulmonary Artery Thrombosis 2.3%
Concomitant
Idiopathic Thrombocytopenic Purpura 100.0%
Pulmonary Haemorrhage 100.0%